Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy.
Infante MS, Nemirovsky D, Devlin S, DeWolf S, Tamari R, Dahi PB, Lee YJ, Chung DJ, Politikos I, Barker J, Giralt SA, Babady NE, Ramanathan L, Papanicolaou GA, Seo S, Kamboj M, Perales MA, Shah GL.
Infante MS, et al. Among authors: papanicolaou ga.
Transplant Cell Ther. 2024 Jan;30(1):116.e1-116.e12. doi: 10.1016/j.jtct.2023.09.027. Epub 2023 Oct 6.
Transplant Cell Ther. 2024.
PMID: 37806446